0001209191-19-009950.txt : 20190213
0001209191-19-009950.hdr.sgml : 20190213
20190213211433
ACCESSION NUMBER: 0001209191-19-009950
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190213
FILED AS OF DATE: 20190213
DATE AS OF CHANGE: 20190213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rajpal Rajesh K.
CENTRAL INDEX KEY: 0001767449
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38809
FILM NUMBER: 19600161
MAIL ADDRESS:
STREET 1: C/O AVEDRO, INC., 201 JONES ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVEDRO INC
CENTRAL INDEX KEY: 0001343304
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 201 JONES ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781 768 3400
MAIL ADDRESS:
STREET 1: 201 JONES ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-02-13
0
0001343304
AVEDRO INC
AVDR
0001767449
Rajpal Rajesh K.
C/O AVEDRO, INC.
201 JONES ROAD
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
Common Stock
1895
D
Series AA Convertible Preferred Stock
Common Stock
3620
D
Series BB Convertible Preferred Stock
Common Stock
444
D
Series CC Convertible Preferred Stock
Common Stock
1284
D
Employee Stock Option (right to buy)
46.01
2021-08-12
Common Stock
141
D
Employee Stock Option (right to buy)
35.42
2023-04-21
Common Stock
70
D
Employee Stock Option (right to buy)
1.34
2026-03-24
Common Stock
53146
D
Employee Stock Option (right to buy)
2.14
2028-01-30
Common Stock
24917
D
Employee Stock Option (right to buy)
2.14
2028-01-30
Common Stock
53146
D
Employee Stock Option (right to buy)
3.69
2028-07-17
Common Stock
30561
D
Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock is convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
Fully vested.
One forty-eighth (1/48th) of the shares subject to the option shall vest on a monthly basis commencing on April 16, 2016, subject to the Reporting Person continuing to provide service through each such date.
One forty-eighth (1/48th) of the shares subject to the option shall vest on a monthly basis commencing on March 1, 2018, subject to the Reporting Person continuing to provide service through each such date.
19,375 of the shares subject to the option vested immediately as February 1, 2018 (the "Vesting Commencement Date"), with the remainder vesting in 24 equal installments over a two-year period beginning on the first monthly anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to provide service through each such date.
One forty-eighth (1/48th) of the shares subject to the option shall vest on a monthly basis commencing on July 21, 2018, subject to the Reporting Person continuing to provide service through each such date.
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Paul S. Bavier, Attorney-in-Fact
2019-02-13
EX-24.3_832918
2
poa.txt
POA DOCUMENT
Exhibit 24
POWER OF ATTORNEY
(For Executing Form ID and Forms 3, 4 and 5)
Know all by these presents, that the undersigned hereby constitutes and
appoints each of Paul S. Bavier and Thomas E. Griffin of Avedro, Inc. (the
"Company") and Marc Recht, Courtney Thorne, Esther Cho and Jason Minio of Cooley
LLP, signing individually, the undersigned's true and lawful attorneys-in fact
and agents to:
(1) Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission (the "SEC"), a Form ID and
Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in
connection therewith) in accordance with Section 16 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, in the
undersigned's capacity as an officer, director or beneficial owner of more than
10% of a registered class of securities of the Company;
(2) Do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to prepare and execute any such Form ID and Forms
3, 4 or 5 (including amendments thereto and joint filing agreements in
connection therewith) and file such forms with the SEC and any stock exchange,
self-regulatory association or any similar authority; and
(3) Take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required of the undersigned, it being
understood that the documents executed by the attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as the attorney-in-fact may approve in the
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, and their
substitutes, in serving in such capacity at the request of the undersigned, are
not assuming (nor is the Company assuming) any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the Company and the foregoing attorneys-in fact or (c) as to any
attorney-in-fact individually, until such attorney-in-fact is no longer employed
by the Company or employed by or a partner at Cooley LLP or another law firm
representing the Company, as applicable.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.
Date: 2/7/19
/s/ Rajesh K. Rajpal
Rajesh K. Rajpal